Dr. Snyder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4101 N Roxboro St
Durham, NC 27704Phone+1 919-684-8111
Education & Training
- Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
- University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
- Duke University School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2001 - Present
- NC State Medical License 2003 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization Start of enrollment: 2019 May 01
- Long Term Follow up of the LTOG Cohort Start of enrollment: 2021 Jun 15
Publications & Presentations
PubMed
- 2 citationsPerspectives on donor lung allocation from both sides of the Atlantic: The United StatesWayne Tsuang, Laurie D. Snyder, Marie Budev
Clinical Transplantation. 2020-04-09 - 274 citationsAntibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung TransplantationDeborah Levine, Allan R. Glanville, C.L Aboyoun, John A. Belperio, Christian Benden
The Journal of Heart and Lung Transplantation. 2016-04-01 - 16 citationsTime to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO RegistryLaurie D. Snyder, Chris Mosher, Colin Holtze, Lisa Lancaster, Kevin R. Flaherty
BMJ Open Respiratory Research. 2020-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: